Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Long-Term Debt Repayments (2019 - 2021)

GeoVax Labs (GOVX) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $24801.0 as the latest value for Q2 2021.

  • On a quarterly basis, Long-Term Debt Repayments rose 740.14% to $24801.0 in Q2 2021 year-over-year; TTM through Mar 2022 was $24801.0, a 106.18% increase, with the full-year FY2024 number at $150000.0, changed N/A from a year prior.
  • Long-Term Debt Repayments was $24801.0 for Q2 2021 at GeoVax Labs, up from $3063.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $24801.0 in Q2 2021 to a low of $1924.0 in Q4 2019.
  • A 3-year average of $5000.1 and a median of $3007.0 in 2020 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: fell 5.57% in 2020, then skyrocketed 740.14% in 2021.
  • GeoVax Labs' Long-Term Debt Repayments stood at $1924.0 in 2019, then surged by 57.28% to $3026.0 in 2020, then skyrocketed by 719.6% to $24801.0 in 2021.
  • Per Business Quant, the three most recent readings for GOVX's Long-Term Debt Repayments are $24801.0 (Q2 2021), $3063.0 (Q1 2021), and $3026.0 (Q4 2020).